Amlodipine-induced gingival overgrowth.

Amlodipine- induced gingival overgrowth: a case report.

Drug-induced gingival overgrowth occurs in genetically susceptibIe individuals as a side effect of various drugs. There is a gross disfiguring enlargement of gingiva mostly in the anterior region leading to difficulty in mastication, speech and maintenance of oral hygiene. In this case report, amlodipine-induced gingival enlargement and its management are discussed. Drug substituion, appropriat...

Amlodipin-induced Gingival Overgrowth and Application of Er:yag Laser in the Treatment Protocol

295 ABSTRACT: Gingival overgrowth (GO) is one of the most important clinical features of gingival pathology. Amlodipine is a comparatively new III generation calcium channels blocker, used for management of cardiovascular disorders. Although it is considered safe, it can also rarely induce GO. A case of severe amlodipine-induced GO, complicated by inflammatory changes due to plaque accumulation...

Prevalence of Amlodipine-induced Gingival Overgrowth

Amlodipine induced gingival overgrowth: A case report

Introduction: Drug-induced gingival overgrowth (DIGO) remains a significant problem for the dental clinicians and the periodontologists. Patients medicated with certain drugs may be implicated in this unwanted side effect, which may interfere with esthetics, mastication or speech. Case Report: The case presented here is a 60-year-old female patient with drug induced gingival enlargement. Patien...

Case report: drug-induced gingival overgrowth associated with the use of a calcium channel blocker (amlodipine).

INTRODUCTION Many factors can contribute to the development of gingival overgrowth (hyperplasia), including: plaque control; periodontal variables; medications and their relative dose; age; sex; and, genetic factors. Nifedipine is a calcium channel blocker commonly reported to result in drug-induced gingival overgrowth (DIGO). This report outlines a case of gingival overgrowth induced by amlodi...